CanSino Biologics Financials
| CJH Stock | 3.66 0.12 3.17% |
CanSino |
Understanding current and past CanSino Biologics Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of CanSino Biologics' financial statements are interrelated, with each one affecting the others. For example, an increase in CanSino Biologics' assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in CanSino Biologics' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of CanSino Biologics. Check CanSino Biologics' Beneish M Score to see the likelihood of CanSino Biologics' management manipulating its earnings.
| Instrument | Germany Stock View All |
| Exchange | Stuttgart Exchange |
| ISIN | CNE100003F01 |
| Business Address | 401-420, Biomedical Park, |
| Sector | Healthcare |
| Industry | Drug Manufacturers-Specialty & Generic |
| Benchmark | Dow Jones Industrial |
| Website | www.cansinotech.com |
| Phone | 400 922 2099 |
You should never invest in CanSino Biologics without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of CanSino Stock, because this is throwing your money away. Analyzing the key information contained in CanSino Biologics' financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
CanSino Biologics Key Financial Ratios
CanSino Biologics' financial ratios allow both analysts and investors to convert raw data from CanSino Biologics' financial statements into concise, actionable information that can be used to evaluate the performance of CanSino Biologics over time and compare it to other companies across industries.| Return On Equity | 0.0111 | |||
| Return On Asset | -0.0207 | |||
| Beta | 0.61 | |||
| Z Score | 47.4 |
CanSino Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining CanSino Biologics's current stock value. Our valuation model uses many indicators to compare CanSino Biologics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across CanSino Biologics competition to find correlations between indicators driving CanSino Biologics's intrinsic value. More Info.CanSino Biologics is rated third in return on equity category among its peers. It is rated second in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the CanSino Biologics' earnings, one of the primary drivers of an investment's value.CanSino Biologics Systematic Risk
CanSino Biologics' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. CanSino Biologics volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on CanSino Biologics correlated with the market. If Beta is less than 0 CanSino Biologics generally moves in the opposite direction as compared to the market. If CanSino Biologics Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one CanSino Biologics is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of CanSino Biologics is generally in the same direction as the market. If Beta > 1 CanSino Biologics moves generally in the same direction as, but more than the movement of the benchmark.
CanSino Biologics Thematic Clasifications
CanSino Biologics is part of several thematic ideas from Soft Drinks to Beers. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Get More Thematic IdeasCanSino Biologics December 26, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of CanSino Biologics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of CanSino Biologics. We use our internally-developed statistical techniques to arrive at the intrinsic value of CanSino Biologics based on widely used predictive technical indicators. In general, we focus on analyzing CanSino Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build CanSino Biologics's daily price indicators and compare them against related drivers.
| Downside Deviation | 4.7 | |||
| Information Ratio | 0.1355 | |||
| Maximum Drawdown | 30.83 | |||
| Value At Risk | (5.82) | |||
| Potential Upside | 13.07 |
Additional Tools for CanSino Stock Analysis
When running CanSino Biologics' price analysis, check to measure CanSino Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CanSino Biologics is operating at the current time. Most of CanSino Biologics' value examination focuses on studying past and present price action to predict the probability of CanSino Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CanSino Biologics' price. Additionally, you may evaluate how the addition of CanSino Biologics to your portfolios can decrease your overall portfolio volatility.